Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to a diverse array of exogenous substances, including pharmaceutical agents, environmental toxins, and hazardous chemicals, that are present within the gastrointestinal lumen following oral ingestion. In clinical toxicology, these substances are the focus of decontamination efforts aimed at preventing systemic absorption and subsequent toxicity. The most common pharmacological intervention is the administration of activated charcoal, which acts as a non-specific adsorbent by trapping molecules within its porous structure (StatPearls, NBK482294). This process is highly dependent on the timing of administration and the chemical properties of the ingested substance, such as its molecular size and polarity. While not a biological macromolecule like a receptor or enzyme, these substances represent the physical target for agents designed to mitigate the effects of poisoning (Wikipedia, Activated charcoal (medication)). Effective management of these substances is a cornerstone of emergency medicine for treating drug overdoses and accidental poisonings (NIH, MedlinePlus). However, certain substances like alcohols, hydrocarbons, and corrosive agents are not effectively targeted by standard adsorbents and require specific alternative treatments.
The primary mechanism involves physical adsorption, where the ingested substances bind to the large surface area of an adsorbent like activated charcoal through van der Waals forces and hydrogen bonding, thereby preventing their absorption across the gastrointestinal epithelium into the systemic circulation (StatPearls, NBK482294).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ingested toxins and drugs in the gastrointestinal lumen.